SSGJ-705

Other Medications

1 Clinical Trials

Description

SSGJ-705 is an investigational medication currently being studied in clinical trials for certain types of advanced solid tumors, including colorectal cancer. It is being investigated specifically in patients whose tumors express HER2. The drug is being tested in combination with another investigational drug, SSGJ-612, sometimes with or without standard chemotherapy. The goal of these trials is to see if SSGJ-705, alone or in combination, is safe and effective in treating these cancers. It is important to note that SSGJ-705 is not yet approved for use in colorectal cancer or any other cancer.

Mechanism of Action

The specific way SSGJ-705 works (its mechanism of action) is still being investigated in clinical trials. It is designed to target processes involved in cancer cell growth and survival. The trials are evaluating its effects on HER2-expressing tumors.

Side Effects

As SSGJ-705 is an investigational drug Its side effects are still being evaluated in ongoing clinical trials. The specific side effects and how common they are are not yet fully known. Patients participating in these trials are closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07646626 Phase 2
Recruiting
SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
China

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.